Literature DB >> 26828871

Samples and techniques highlighting the links between obesity and microbiota.

Emmanouil Angelakis1, Jean-Christophe Lagier2.   

Abstract

The composition of gut microbiota and its relationship to human health, particularly its links with obesity remain an ongoing challenge for scientists. The current gold standard for exploring human gut microbiota consists of using stool samples and only applying next generations sequencing techniques, which sometimes generate contradictory results. Here, we comprehensively describe nutrient absorption, fat digestion, carbohydrate and protein absorption, demonstrating that absorption of these diverse nutrients occurs mainly in the stomach and small intestine. Indeed, bariatric surgery, including Roux-en-Y, removes part of the upper intestine, resulting in weight loss, while colonic surgery is associated with a stable weight. However, most studies only use stool samples rather than small intestine samples because of the easy with which this can be accessed. Metagenomics studies are associated with several biases such as extraction and primer biases and depth bias, including the more modern platforms. High-throughput culture-dependent techniques, such as culturomics, which uses rapid identification methods such as MALDI-TOF, remain time-consuming, but have demonstrated their complementarity with molecular techniques. In conclusion, we believe that a comprehensive analysis of the relationships between obesity and gut microbiota requires large-scale studies coupling metagenomics and culture-dependent research, in order to analyse both small intestine and stool samples.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Culturomics; Gut microbiota; Metagenomics; Small intestine samples; Stool samples

Mesh:

Year:  2016        PMID: 26828871     DOI: 10.1016/j.micpath.2016.01.024

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  10 in total

1.  Succinylsulfathiazole modulates the mTOR signaling pathway in the liver of c57BL/6 mice via a folate independent mechanism.

Authors:  Safa Beydoun; Ali M Fardous; Michael M Saruna; Ali G Beydoun; Johnathan A Sorge; Hongzhi Ma; Ghada Aoun; Archana Unnikrishnan; Diane C Cabelof; Ahmad R Heydari
Journal:  Exp Gerontol       Date:  2021-05-03       Impact factor: 4.253

2.  A fibrolytic potential in the human ileum mucosal microbiota revealed by functional metagenomic.

Authors:  Orlane Patrascu; Fabienne Béguet-Crespel; Ludovica Marinelli; Emmanuelle Le Chatelier; Anne-Laure Abraham; Marion Leclerc; Christophe Klopp; Nicolas Terrapon; Bernard Henrissat; Hervé M Blottière; Joël Doré; Christel Béra-Maillet
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

3.  Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.

Authors:  Janina A Krumbeck; Heather E Rasmussen; Robert W Hutkins; Jennifer Clarke; Krista Shawron; Ali Keshavarzian; Jens Walter
Journal:  Microbiome       Date:  2018-06-28       Impact factor: 14.650

4.  The Human Microbiota and Obesity: A Literature Systematic Review of In Vivo Models and Technical Approaches.

Authors:  Lucrecia Carrera-Quintanar; Daniel Ortuño-Sahagún; Noel N Franco-Arroyo; Juan M Viveros-Paredes; Adelaida S Zepeda-Morales; Rocio I Lopez-Roa
Journal:  Int J Mol Sci       Date:  2018-11-30       Impact factor: 5.923

5.  In Vivo Healthy Benefits of Galacto-Oligosaccharides from Lupinus albus (LA-GOS) in Butyrate Production through Intestinal Microbiota.

Authors:  Lucila A Godínez-Méndez; Carmen M Gurrola-Díaz; José Sergio Zepeda-Nuño; Natali Vega-Magaña; Rocio Ivette Lopez-Roa; Liliana Íñiguez-Gutiérrez; Pedro M García-López; Mary Fafutis-Morris; Vidal Delgado-Rizo
Journal:  Biomolecules       Date:  2021-11-09

6.  Anti-Obesity Effect of Theabrownin from Dark Tea in C57BL/6J Mice Fed a High-Fat Diet by Metabolic Profiles through Gut Microbiota Using Untargeted Metabolomics.

Authors:  Hang-Yu Li; Si-Yu Huang; Ruo-Gu Xiong; Si-Xia Wu; Dan-Dan Zhou; Adila Saimaiti; Min Luo; Hui-Lian Zhu; Hua-Bin Li
Journal:  Foods       Date:  2022-09-27

7.  Taxonogenomic description of four new Clostridium species isolated from human gut: 'Clostridium amazonitimonense', 'Clostridium merdae', 'Clostridium massilidielmoense' and 'Clostridium nigeriense'.

Authors:  M T Alou; S Ndongo; L Frégère; N Labas; C Andrieu; M Richez; C Couderc; J-P Baudoin; J Abrahão; S Brah; A Diallo; C Sokhna; N Cassir; B La Scola; F Cadoret; D Raoult
Journal:  New Microbes New Infect       Date:  2017-11-22

Review 8.  Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research.

Authors:  Shaocun Zhang; Xiaocang Cao; He Huang
Journal:  Front Cell Infect Microbiol       Date:  2017-02-24       Impact factor: 5.293

9.  Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.

Authors:  Da Jung Kim; Seonghae Yoon; Sang Chun Ji; Jinho Yang; Yoon-Keun Kim; SeungHwan Lee; Kyung-Sang Yu; In-Jin Jang; Jae-Yong Chung; Joo-Youn Cho
Journal:  Sci Rep       Date:  2018-08-08       Impact factor: 4.379

10.  Changes in the intestinal microbiota of superobese patients after bariatric surgery.

Authors:  Denis Pajecki; Lea Campos de Oliveira; Ester Cerdeira Sabino; Marcela de Souza-Basqueira; Anna Carolina Batista Dantas; Gabriel Cairo Nunes; Roberto de Cleva; Marco Aurélio Santo
Journal:  Clinics (Sao Paulo)       Date:  2019-10-28       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.